Elsevier First to Publish NADAC Price Type from CMS
Elsevier's Gold Standard is the first drug database to include CMS's survey-based pricing, making it the most comprehensive source for drug price benchmarks
world-leading provider of scientific, technical and medical information
products and services, announced today that, effective November 30, 2013, the
Centers for Medicare & Medicaid Services' (CMS) survey-based price type, National
Average Drug Acquisition Cost (NADAC) is included for all available drugs
where applicable in Elsevier's Gold
Standard Drug Database and web-based solutions, ProspectoRx
CMS invested in NADAC, which is based on a monthly voluntary survey of randomly selected pharmacies nationwide. NADAC was created in order to provide Medicaid agencies with a better estimate of prices paid by pharmacies for drugs, which would be based upon actual drug purchases. The NADAC file is updated on a weekly basis and each month a new survey file is posted to reflect findings from the previous month's survey results. Elsevier publishes both the weekly price type file and monthly file.
"NADAC is another option for a new drug price benchmark that our customers, and the industry as a whole, may decide to use," said Kay Morgan, Vice President of Drug Products and Industry Standards, Elsevier. "We at Elsevier strive to provide the most accurate and continuously updated data for our users."
Elsevier's Gold Standard Drug Database pricing file is the only compendia that continues to publish Average Wholesale Price (AWP), along with several other price types: Wholesale Acquisition Cost (WAC), Direct Price (DP), Federal Supply Schedule (FSS), CMS Federal Upper Limit (CMS-FUL), Maximum Allowable Cost (MAC), and Predictive Acquisition Cost (PAC). Elsevier's drug pricing database delivers the most up-to-the-minute data available via web-based solutions, ProspectoRx and RxPrice Verify.
For more information about Elsevier's Gold Standard, visit www.goldstandard.com.
# # #
Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions — among them ScienceDirect, Scopus, Elsevier Research Intelligence and ClinicalKey— and publishes over 2,500 journals, including The Lancet and Cell, and more than 35,000 book titles, including a number of iconic reference works. Elsevier is part of RELX Group, a world-leading provider of information and analytics for professional and business customers across industries. www.elsevier.com
Director, Corporate Relations, Elsevier
+1 212 633 3164